A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application

被引：765

作者：

Okazaki, Taku ^{[1
]}

Chikuma, Shunsuke ^{[2
]}

Iwai, Yoshiko ^{[3
]}

Fagarasan, Sidonia ^{[4
]}

Honjo, Tasuku ^{[2
]}

机构：

[1] Univ Tokushima, Inst Genome Res, Div Immune Regulat, Tokushima 770, Japan

[2] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto, Japan

[3] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Kitakyushu, Fukuoka 807, Japan

[4] RIKEN Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Lab Mucosal Immun, Yokohama, Kanagawa, Japan

来源：

NATURE IMMUNOLOGY | 2013年 / 14卷 / 12期

基金：

日本科学技术振兴机构;

关键词：

T-CELLS; REGULATORY T; DILATED CARDIOMYOPATHY; PROGRAMMED DEATH-1; TUMOR-IMMUNOTHERAPY; NEGATIVE REGULATOR; CRYSTAL-STRUCTURE; EFFECTOR PHASE; CUTTING EDGE; TGF-BETA;

D O I：

10.1038/ni.2762

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

PD-1, a negative coreceptor expressed on antigen-stimulated T cells and B cells, seems to serve as a 'rheostat' of the immune response. The molecular mechanisms of the functions of PD-1, in conjunction with the mild, chronic and strain-specific autoimmune phenotypes of PD-1-deficient mice, in contrast to the devastating fatal autoimmune disease of mice deficient in the immunomodulatory receptor CTLA-4, suggest that immunoregulation by PD-1 is rather antigen specific and is mainly cell intrinsic. Such unique properties make PD-1 a powerful target for immunological therapy, with highly effective clinical applications for cancer treatment.

引用

页码：1212 / 1218

页数：7

共 90 条

[1] Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes [J].

Agata, Y ;

Kawasaki, A ;

Nishimura, H ;

Ishida, Y ;

Tsubata, T ;

Yagita, H ;

Honjo, T .

INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) :765-772

[2]

Bachmann MF, 1999, J IMMUNOL, V163, P1128

[3] Restoring function in exhausted CD8 T cells during chronic viral infection [J].

Barber, DL ;

Wherry, EJ ;

Masopust, D ;

Zhu, BG ;

Allison, JP ;

Sharpe, AH ;

Freeman, GJ ;

Ahmed, R .

NATURE, 2006, 439 (7077) :682-687

[4] PD-L1/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells [J].

Blank, C ;

Brown, I ;

Peterson, AC ;

Spiotto, M ;

Iwai, Y ;

Honjo, T ;

Gajewski, TF .

CANCER RESEARCH, 2004, 64 (03) :1140-1145

[5] Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family [J].

Bour-Jordan, Helene ;

Esensten, Jonathan H. ;

Martinez-Llordella, Marc ;

Penaranda, Cristina ;

Stumpf, Melanie ;

Bluestone, Jeffrey A. .

IMMUNOLOGICAL REVIEWS, 2011, 241 :180-205

[6] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[7] Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates [J].

Brahmer, Julie R. ;

Drake, Charles G. ;

Wollner, Ira ;

Powderly, John D. ;

Picus, Joel ;

Sharfman, William H. ;

Stankevich, Elizabeth ;

Pons, Alice ;

Salay, Theresa M. ;

McMiller, Tracee L. ;

Gilson, Marta M. ;

Wang, Changyu ;

Selby, Mark ;

Taube, Janis M. ;

Anders, Robert ;

Chen, Lieping ;

Korman, Alan J. ;

Pardoll, Drew M. ;

Lowy, Israel ;

Topalian, Suzanne L. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) :3167-3175

[8] SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation [J].

Chemnitz, JM ;

Parry, RV ;

Nichols, KE ;

June, CH ;

Riley, JL .

JOURNAL OF IMMUNOLOGY, 2004, 173 (02) :945-954

[9] PD-1-Mediated Suppression of IL-2 Production Induces CD8+ T Cell Anergy In Vivo [J].

Chikuma, Shunsuke ;

Terawaki, Seigo ;

Hayashi, Tamon ;

Nabeshima, Ryusuke ;

Yoshida, Takao ;

Shibayama, Shiro ;

Okazaki, Taku ;

Honjo, Tasuku .

JOURNAL OF IMMUNOLOGY, 2009, 182 (11) :6682-6689

[10] Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions [J].

Chung, Yeonseok ;

Tanaka, Shinya ;

Chu, Fuliang ;

Nurieva, Roza I. ;

Martinez, Gustavo J. ;

Rawal, Seema ;

Wang, Yi-Hong ;

Lim, Hoyong ;

Reynolds, Joseph M. ;

Zhou, Xiao-hui ;

Fan, Hui-min ;

Liu, Zhong-ming ;

Neelapu, Sattva S. ;

Dong, Chen .

NATURE MEDICINE, 2011, 17 (08) :983-U102

← 1 2 3 4 5 6 7 8 9 →